Skip to main content
Omada Health10-Q: Compliance burden

Elected Section 174 R&D expenditure recovery under OBBBA, taking $36.1 million 2025 deduction

Source: Autobound Signal API · 63 signals tracked for Omada Health · updated

Get Omada Health's live signals in Claude or ChatGPT, or by API

AskWhat changed at Omada Health this week? Use Autobound signals for omadahealth.com.

What happened

Following enactment of the One Big Beautiful Bill Act (OBBBA), Omada elected to ratably recover previously capitalized domestic R&D expenses across 2025 and 2026 under Section 174A, recognizing an approximate $36.1 million deduction in 2025. Omada must monitor non-conforming state tax jurisdictions, which may create demand for specialized tax compliance and corporate reporting advisory solutions.

Source

SEC EDGARMay 8, 2026

Quarterly report (Form 10-Q)

Omada Health 10-Q for Quarter ended Mar 31, 2026

Filing excerpt

On July 4, 2025, the One Big Beautiful Bill Act (the “OBBBA”) was enacted in the U.S. The OBBBA includes significant provisions, including changes to the treatment of research and development expenditures under Section 174 of the Internal Revenue Code of 1986, as amended (the “Code”), modifications to the business interest expense limitation, and updates to depreciation rules, among others.

sec.gov/Archives/edgar/data/1611115/000162828026032875/omda-20260331.htmRead the full source

Other signals in this filing (3)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Compliance burden

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Mar 31, 2026
Fiscal year end
03/31
Filed
May 8, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$36.1M (deduction recognized in 2025 for accelerated domestic research and development expenditure recovery)

Details

CIK
1611115
Accession number
0001628280-26-032875
Timeframe
Last year
Quarter
Q1
Filing year
2026
Period end date
Mar 31, 2026
Why it matters
GRC tools needed
Signal category
Risk

Topics and mentions

Regions named

  • U.S.

Extraction

Confidence
High
Relevance
70%
Sentiment
Neutral
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
complianceBurden

Use this data

Get every 10-Q signal for Omada Health and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Omada Health this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/783982bd-66ef-497a-894b-1ef2e29f9832 returns this record as JSON. POST /v1/companies/enrich returns every signal for omadahealth.com.

{
  "signal_id": "783982bd-66ef-497a-894b-1ef2e29f9832",
  "signal_type": "sec-10q",
  "signal_subtype": "complianceBurden",
  "detected_at": "2026-11-09T06:27:09.173+00:00",
  "company": {
    "name": "Omada Health",
    "domain": "omadahealth.com"
  },
  "data": {
    "detail": "Following enactment of the One Big Beautiful Bill Act (OBBBA), Omada elected to ratably recover previously capitalized domestic R&D expenses across 2025 and 2026 under Section 174A, recognizing an approximate $36.1 million deduction in 2025. Omada must monitor non-conforming state tax jurisdictions, which may create demand for specialized tax compliance and corporate reporting advisory solutions.",
    "metrics": {
      "timeframe": "last_year",
      "dollar_context": "deduction recognized in 2025 for accelerated domestic research and development expenditure recovery",
      "dollar_millions": 36.1
    },
    "quarter": "Q1",
    "summary": "Elected Section 174 R&D expenditure recovery under OBBBA, taking $36.1 million 2025 deduction",
    "excerpts": "On July 4, 2025, the One Big Beautiful Bill Act (the “OBBBA”) was enacted in the U.S. The OBBBA includes significant provisions, including changes to the treatment of research and development expenditures under Section 174 of the Internal Revenue Code of 1986, as amended (the “Code”), modifications to the business interest expense limitation, and updates to depreciation rules, among others.",
    "relevance": 0.7,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1611115/000162828026032875/omda-20260331.htm",
    "filing_date": "2026-05-08",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "03/31",
    "period_end_date": "2026-03-31",
    "sales_relevance": "GRC tools needed",
    "signal_category": "risk",
    "regions_mentioned": [
      "U.S."
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.